Novaarc Surgicals Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 03-07-2024
- Paid Up Capital ₹ 0.15 M
as on 03-07-2024
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
About Novaarc Surgicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Santosh Janna, Vijaykumar Kangoni, and Deepa Patil serve as directors at the Company.
- CIN/LLPIN
U52601KA2018PTC118460
- Company No.
118460
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Nov 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Novaarc Surgicals Private Limited offer?
Novaarc Surgicals Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Rehabilitation Equipment, Orthopedic Equipment & Supplies, Prostheses, Compression Stockings, Plaster Room Equipment, Orthopedic Implants, Bandages & Dressing Disposables, Bandages, Surgical Instruments & Accessories.
Who are the key members and board of directors at Novaarc Surgicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Janna  | Director | 13-Nov-2018 | Current |
| Vijaykumar Kangoni | Director | 13-Nov-2018 | Current |
Deepa Patil  | Director | 24-Apr-2019 | Current |
Financial Performance of Novaarc Surgicals.
Novaarc Surgicals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Novaarc Surgicals?
Unlock access to Novaarc Surgicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Click 4-G Medicines Opc Private LimitedActive 9 years 7 monthsVijaykumar Kangoni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Novaarc Surgicals?
Unlock and access historical data on people associated with Novaarc Surgicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novaarc Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novaarc Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
